BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22704273)

  • 21. [Clinical study of the sentinel lymph node of patients with laryngeal and hypopharyngeal carcinomas].
    Fang J; Wei X; Li S; Wang C; Tian A; Tao Y; Sun X; Zou S; Li M; Cai S; Luan X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):244-6. PubMed ID: 12761986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The assessment of the modified radical neck dissection in the treatment of laryngeal cancer].
    Chodynicki S; Lazarczyk B; Woińska T; Południewska B; Tynkiewicz J; Olszewska E
    Otolaryngol Pol; 2000; 54 Suppl 31():148-50. PubMed ID: 10974870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neck dissection of level IIb: is it really necessary?
    Corlette TH; Cole IE; Albsoul N; Ayyash M
    Laryngoscope; 2005 Sep; 115(9):1624-6. PubMed ID: 16148706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cervical metastasis in patients with T2-4 cN0 laryngeal carcinoma].
    Jia SS; He HJ; Xiang C; Liu WS
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):24-7. PubMed ID: 15127564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma.
    Koo BS; Yoon YH; Kim JM; Choi EC; Lim YC
    Ann Surg Oncol; 2009 May; 16(5):1344-7. PubMed ID: 19224280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
    Tao L; Lefèvre M; Callard P; Périé S; Bernaudin JF; St Guily JL
    Otolaryngol Head Neck Surg; 2006 Sep; 135(3):445-50. PubMed ID: 16949980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult lymph node metastasis in laryngeal squamous cell carcinoma: therapeutic and prognostic impact.
    Mnejja M; Hammami B; Bougacha L; Chakroun A; Charfeddine I; Khabir A; Boudaoura T; Ghorbel A
    Eur Ann Otorhinolaryngol Head Neck Dis; 2010 Nov; 127(5):173-6. PubMed ID: 21106463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Routine inclusion of level IV in neck dissection for squamous cell carcinoma of the larynx: is it justified?
    Khafif A; Fliss DM; Gil Z; Medina JE
    Head Neck; 2004 Apr; 26(4):309-12. PubMed ID: 15054733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications.
    Redaelli de Zinis LO; Nicolai P; Tomenzoli D; Ghizzardi D; Trimarchi M; Cappiello J; Peretti G; Antonelli AR
    Head Neck; 2002 Oct; 24(10):913-20. PubMed ID: 12369069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Level IIb lymph node metastasis in elective neck dissection of oropharyngeal squamous cell carcinoma.
    Lee SY; Lim YC; Song MH; Lee JS; Koo BS; Choi EC
    Oral Oncol; 2006 Nov; 42(10):1017-21. PubMed ID: 16757201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
    Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
    Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IIb or not IIb: oncologic role of submuscular recess inclusion in selective neck dissections.
    Hoyt BJ; Smith R; Smith A; Trites J; Taylor SM
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):689-93. PubMed ID: 19128677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracapsular spread of squamous cell carcinoma in neck lymph nodes: prognostic factor of laryngeal cancer.
    Hirabayashi H; Koshii K; Uno K; Ohgaki H; Nakasone Y; Fujisawa T; Syouno N; Hinohara T; Hirabayashi K
    Laryngoscope; 1991 May; 101(5):502-6. PubMed ID: 2030629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation of cervical lymphatic metastasis to prognosis of T3-T4 glottic cancer].
    Yu WB; Zeng ZY; Chen FJ; Zhang Q; Guo ZM; Li H; Liu XK; Wu GH
    Ai Zheng; 2006 Oct; 25(10):1271-4. PubMed ID: 17059774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship between lymph node size and metastasis and extracapsular spread in squamous cell carcinoma of the larynx, orohypopharynx, and oral cavity].
    Oztürk C; Saraydarğolu O; Erişen L; Coşkun H; Basut O; Kasapoğlu F
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(1):7-13. PubMed ID: 18443396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neck dissection of Levels II and III for the treatment of supraglottic laryngeal cancer with clinically negative neck].
    Jia SS; Wang YY; He HJ; Xiang C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):747-50. PubMed ID: 21092673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphatic metastases to level IIb in hypopharyngeal squamous cell carcinoma.
    Kim YH; Koo BS; Lim YC; Lee JS; Kim SH; Choi EC
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1060-4. PubMed ID: 17043251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the significance of level IIb neck dissection for hypopharyngeal cancer.
    Sakai A; Okami K; Sugimoto R; Ebisumoto K; Yamamoto H; Maki D; Atsumi T; Saito K; Iida M
    Head Neck; 2013 Dec; 35(12):1777-80. PubMed ID: 23508589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer.
    Villaret AB; Piazza C; Peretti G; Calabrese L; Ansarin M; Chiesa F; Pellini R; Spriano G; Nicolai P
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):897-903. PubMed ID: 17875856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?
    Lim YC; Lee JS; Choi EC
    Acta Otolaryngol; 2009 Jan; 129(1):57-61. PubMed ID: 18607981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.